The aim of the present study was to assess the association between primary tumor expression of six selected folate pathway genes, ABCC3, RFC‐1, PCFT, MFT, MTHFD2, and TYMS, and tumor response as well as 3‐year progression‐free survival (PFS) of patients with mCRC. The gene discussed is MTHFD2; the disease is neoplasm.